Epithelix Sàrl offers in vitro solutions, such as Non-Animal Methodologies (NAM) and Micro Physiological Systems (MPS), for drug efficacy evaluation and chemical compound toxicity assessment on the human respiratory tract. The company is engaged in various research projects with clinical therapeutic aims, including treatments for respiratory disease patients. Additionally, Epithelix provides innovative in vitro testing services in its laboratory, utilizing its commercially available products.
